| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 09/10/2004 | CA2517386A1 4-(3- (2-phenyl-oxazol-4-ylmethoxy)-cyclohexyloxy)-butane acid derivatives and related compounds as ppar modulators for treating diabetes of type 2 and atherosclerosis |
| 09/10/2004 | CA2517381A1 3-(2-phenyl-oxazol-4-yl methoxy) cyclohexylmethoxy acetic acid derivatives and related compounds used as ppar modulators for treating type 2 diabetes and arteriosclerosis |
| 09/10/2004 | CA2517307A1 1,3-substituted cycloalkyl derivatives containing acidic, mainly heterocyclic groups, corresponding production method and use of said derivatives as medicaments |
| 09/10/2004 | CA2516824A1 Pyrazolo[1,5-a]pyrimidine derivatives |
| 09/10/2004 | CA2516660A1 Novel benzimidazole and imidazopyridine derivatives and use thereof as a medicament |
| 09/10/2004 | CA2516657A1 Cycloalkyl derivatives comprising bioisosteric carboxylic acid groups, method for the production thereof, and use thereof as a medicament |
| 09/10/2004 | CA2516633A1 Cycloalkyl-substituted alkanoic acid derivatives, methods for the production thereof, and use thereof as a medicament |
| 09/10/2004 | CA2516620A1 3-methyl-2- (3- (2-phenyl-oxazol-4-ylmethoxy)-cyclohexanecarbonyl-amino butyric acid derivatives and related compounds as ppar modulators for the treatment of type 2 diabetes and atherosclerosis |
| 09/10/2004 | CA2516573A1 Diarylcycloalkyl derivatives, method for their production and their use as medicaments |
| 09/10/2004 | CA2516407A1 Heteroarylcarbamoylbenzene derivatives |
| 09/10/2004 | CA2515963A1 Phenyl- and pyridylpiperidine-derivatives as modulators of glucose metabolism |
| 09/09/2004 | US20040176601 Benzimisazo[4,5-f]isoquinolinone derivatives |
| 09/09/2004 | US20040176595 Glucocorticoid receptor modulators |
| 09/09/2004 | US20040176567 Bioactive peptides comprising enhanced solubility and reduced aggregatory characteristics for use in diagnosis, prevention and treatment of hypercalaemia, osteoporosis and paget's disease |
| 09/09/2004 | US20040176476 Pharmaceutical composition |
| 09/09/2004 | US20040176473 Methods for delivering compounds into a cell |
| 09/09/2004 | US20040176462 NPY Y5 antagonist |
| 09/09/2004 | US20040176451 Pparg agonistic medicinal compositions |
| 09/09/2004 | US20040176444 Phenylalkyloxy-phenyl derivatives |
| 09/09/2004 | US20040176438 Novel mono- and di-fluorinated beozothiepine copmunds as inhibitors of apical sodium co-dependent bile acid transport (ASBT) and taurocholate uptake |
| 09/09/2004 | US20040176434 Pyrazoloanthrone derivatives as Jun N-terminal kinase inhibitors; diabetes; obesity |
| 09/09/2004 | US20040176428 treatment of Type 2 diabetes mellitus, obesity and lipid disorders; coadministration with HMG CoA reductase inhibitors |
| 09/09/2004 | US20040176427 Alpha type human peroxisome proliferator activated receptor agonists; such as 2-methyl-2-(3-methyl-4-(((4-phenoxymethyl-2-(4-trifluoromethylphenyl) -thiazol-5-yl-carbonyl)-amino)-methyl)phenoxy)propionic acid |
| 09/09/2004 | US20040176422 Heteroarylheteroalkylamine derivatives and their use as inhibitors of nitric oxide synthase |
| 09/09/2004 | US20040176417 Substituted 2-thio-3, 5-dicyano-4-phenyl-6-aminopyridines and their use as adenosine receptor-selective ligands |
| 09/09/2004 | US20040176414 principle metabolite of cisapride; has both 5-HT3 antagonistic and 5-HT4 agonistic; devoid of central nervous system effects; separating racemic mixture by liquid chromatography over a chiral stationary phase |
| 09/09/2004 | US20040176411 especially useful for treating asthma and/or rhinitis; example compound N-[[[2-[4-(3,4-dichlorophenoxy)-1-piperidinyl]ethyl]amino]carbonyl]-4-methyl-benzenesulfonamide |
| 09/09/2004 | US20040176406 Pyrido [2,1-a] isoquinoline derivatives |
| 09/09/2004 | US20040176400 Fused pyrimidines as antagonists of the corticotropin releasing factor (crf) |
| 09/09/2004 | US20040176394 Administering heterocyclic esters such as 5-(2,4-Dimethyl-phenyl)-3-(8-hydroxy-quinolin-2-ylamino)-5-methyl-dihydro-furan-2-one for prophylaxis of headaches, sepsis, neurodegenerative diseases, or as analgesics, antiischemic or antidiabetic agents |
| 09/09/2004 | US20040176389 Piperazine oxime dervatives having nk-1 receptor antagonistic activity |
| 09/09/2004 | US20040176386 Compounds |
| 09/09/2004 | US20040176383 similar therapeutic properties to ranolazine, but are more potent and have a longer half-life; fatty acid oxidation inhibitor; treatment of diabetes, damage to skeletal muscles resulting from trauma or shock and cardiovascular disease |
| 09/09/2004 | US20040176379 agonist effect from one or more of a somatostatin subtype receptor; diabetes mellitus, hyperlipidemia, insulin insensitivity, Syndrome X; inhibiting the proliferation of helicobacter pylori |
| 09/09/2004 | US20040176365 1,8-Naphthyridin-2(1H)-one derivatives; antiasthmatic, antihistamine, and bronchodilator agents; nontoxic, side effect reduction |
| 09/09/2004 | US20040176361 2H-Isoquinolin-1-one derivatives as poly/ADP-ribose/ polymerase inhibitors |
| 09/09/2004 | US20040176330 Tyrosine phosphatase (PTP-1B) inhibitors; anticarcinogenic agents; neurodegenerative disorders |
| 09/09/2004 | US20040176326 N-substituted 3-hydroxy-4-pyridinones and pharmaceuticals containing thereof |
| 09/09/2004 | US20040176324 Derivatives of 4,7-ethanothiopyrano[3,4-c]pyrrole-1,3-(2H)-dione, 4,7-epoxy-1H-isoindole-1,3(2H)-dione, and/or 4,7-ethano-1H-pyrrolo[3,4-c]pyridine-1,3(2H)-dione derivatives; autoimmune diseases; anticarcinogenic agents |
| 09/09/2004 | US20040176320 Use of at least one glycoinhibitor substance |
| 09/09/2004 | US20040176319 Cellular uptake of bioactive agents |
| 09/09/2004 | US20040176308 Sodium dependent glucose transporter 1 inhibitors; blocking small intestine absorption of glucose; diabetes |
| 09/09/2004 | US20040176294 Use of thyroid-stimulating hormone to induce lipolysis |
| 09/09/2004 | US20040176285 Tip39 polypeptides |
| 09/09/2004 | US20040176252 Well tolerated; intracellularly increasing cAMP; antiasthmatics, antiinflammatories: regulation of eosinophiles activation and degranulation |
| 09/09/2004 | US20040175803 Interferon-alpha induced gene |
| 09/09/2004 | US20040175740 Using proopiomelanocortin animal mutant to identify modulators of weight and pancreatic disorders |
| 09/09/2004 | US20040175443 Food supplement for increasing lean mass and strength |
| 09/09/2004 | US20040175442 Food supplement for increasing lean mass and strength |
| 09/09/2004 | US20040175436 synthetic zeolites and selected herbal proteins (MPP) which is applied for prevention of the development of neuropathies in persons suffering diabetes; stops the process of apoptosis caused by accumulation of Ca2+ ions in cytplasm of nerve cells |
| 09/09/2004 | US20040175424 Medicine based on anti-hyperglycaemic microcapsules with prolonged release and method for preparing same |
| 09/09/2004 | US20040175421 improved glyburide dissolvability and bioavailability similar to single form dosage; glyburide in the form of fine dispersed particles with diameters of less than 45 mu m or, preferably, less than 35 mu m |
| 09/09/2004 | US20040175420 at least one non-ionic or zwitterionic surfactant and dispersant; improves the efficacy and/or potency of the lipase inhibitor; inter-subject variability in efficacy and/or potency is reduced, as well as the frequency and intensity of side effects |
| 09/09/2004 | US20040175378 Monoclonal antibody 3G4, or an antigen-binding region or immunoconjugate thereof, produced by hybridoma ATCC PTA 4545; binds to phosphatidyl serine |
| 09/09/2004 | US20040175348 formed by spray-drying a solution of an edible organic acid wherein chitosan is dissolved; storage stability |
| 09/09/2004 | DE10308356A1 Cycloalkyl substituierte Alkansäurederivate, Verfahren zu ihrer Herstellung und ihre Anwendung als Arzneimittel Cycloalkyl substituted alkane acid derivatives, processes for their preparation and their use as medicaments |
| 09/09/2004 | DE10306502A1 Substituierte 3-(Benzoylureido)-thiophenderivate, Verfahren zu deren Herstellung und deren Verwendung Substituted 3- (Benzoylureido) -thiophenderivate, processes for their preparation and their use |
| 09/09/2004 | DE10306250A1 Substituierte N-Arylheterozyklen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel Substituted N-Arylheterozyklen, processes for their preparation and their use as medicaments |
| 09/08/2004 | EP1454902A1 N- (substituted five-membered di-or triaza diunsaturated ring)carbonyl guanidine derivateives for the treatment of ischemia |
| 09/08/2004 | EP1454898A1 Novel phenylalanine derivative |
| 09/08/2004 | EP1454641A2 Porous implantable medical device seeded with mammalian cells |
| 09/08/2004 | EP1454629A2 Insulinotrophic agent based on preproglucagon |
| 09/08/2004 | EP1454136A2 Methods and means for influencing intracellular communication and intracellular organelle transport |
| 09/08/2004 | EP1453954A2 Endocrine pancreas differentiation of adipose tissue-derived stromal cells and uses thereof |
| 09/08/2004 | EP1453860A2 Novel glucose-dependant insulins |
| 09/08/2004 | EP1453856A1 Beta-amyloid binding factors and inhibitors thereof |
| 09/08/2004 | EP1453844A2 Use of glycosides of mono- and diacylglycerol as anti-inflammatory agents |
| 09/08/2004 | EP1453832A1 Ring fused pyrazole derivatives |
| 09/08/2004 | EP1453820A1 Substituted 6h-dibenzo c,h]chromenes as estrogenic agents |
| 09/08/2004 | EP1453819A2 Statin-like compounds |
| 09/08/2004 | EP1453811A2 Peroxisome proliferator activated receptor agonists |
| 09/08/2004 | EP1453810A1 Substituted 4-phenyltetrahydroisoquinolines, method for the production thereof, the use thereof as medicaments, in addition to a medicament containing same |
| 09/08/2004 | EP1453798A2 (20s)-1alpha-hydroxy-2-methylene-19-nor-bishomopregnacalciferol and its uses |
| 09/08/2004 | EP1453796A2 Propanolaminomethyltetralines, their preparation and pharmaceutical composition comprising same |
| 09/08/2004 | EP1453795A2 Esters and amides as ppar-alpha agonists |
| 09/08/2004 | EP1453782A2 Substituted phenyl naphthalenes as estrogenic agents |
| 09/08/2004 | EP1453777A1 Functionalized higher diamondoids |
| 09/08/2004 | EP1453544A2 Self-emulsifying formulations of cholesteryl ester transfer protein inhibitors |
| 09/08/2004 | EP1453541A1 Use of a glucokinase activator in combination with a glucagon antagonist for treating type 2 diabetes |
| 09/08/2004 | EP1453539A2 Immunotherapeutic methods and systems |
| 09/08/2004 | EP1453533A1 Migration of hematopoietic stem cells and progenitor cells to th e liver |
| 09/08/2004 | EP1453522A1 Methods for treatment or prophylaxis of aldosterone-mediated pathogenic effectgs in a subject using an epoxy-steroidal aldosterone antagonist |
| 09/08/2004 | EP1453511A1 Tropane derivatives having dopamine reuptake inhibitor activity for the treatment of ischemic diseases |
| 09/08/2004 | EP1453503A2 Ep4 receptor agonist, compositions and methods thereof |
| 09/08/2004 | EP1453501A1 N- aryl-n'-arylcycloalkyl-urea derivatives as mch antagonists for the treatment of obesity |
| 09/08/2004 | EP1453496A2 Composition and method for modulating bar/fxr receptor activity |
| 09/08/2004 | EP1453481A1 Reverse-micellar delivery system for controlled transportation and enhanced absorption of agents |
| 09/08/2004 | EP1379261A4 Method for increasing serotonin levels in a person by administration of a composition incorporating (-)-hydroxycitric acid, and related compositions thereof |
| 09/08/2004 | EP1294867B1 Human site-1 protease promoter |
| 09/08/2004 | EP1272637A4 A METHOD FOR SCREENING FOR AUTOIMMUNE DISEASE BY IDENTIFYING POLYMORPHISMS IN IL-12 p40 |
| 09/08/2004 | EP1254209A4 Bioavailable composition of natural and synthetic hca |
| 09/08/2004 | EP1207896A4 Methods and compositions for reducing serum phosphate levels |
| 09/08/2004 | EP1201664B1 Benzimidazole compounds and drugs containing the same |
| 09/08/2004 | EP1180121B9 Long lasting insulinotropic peptides |
| 09/08/2004 | EP1156057B1 Malto-oligosaccharide derivatives and uses thereof |
| 09/08/2004 | EP1140933B1 Process for preparing n6-substituted deaza-adenosine derivatives |
| 09/08/2004 | EP1094712A4 Hypericin and hypericum extract: specific t-type calcium channel blocker, and their use as t-type calcium channel targeted therapeutics |
| 09/08/2004 | EP1001802B1 A combined pharmaceutical preparation comprising parathyroid hormone and a bone resorption inhibitor |
| 09/08/2004 | EP0739355B1 Kallikrein-inhibiting "kunitz domain" proteins and analogues thereof |
| 09/08/2004 | CN1527830A Ether derivatives useful as inhibitors of PDE4 isozymes |